EGFR and neoplasm: Few studies have highlighted the role of biomarkers in the categorization of BPTs in addition to the fact that some of the studies have controversial results, in our current study, we aimed to evaluate for the first time in Algeria, the prognostic values of EGFR and CD10 among Algerian patients in correlation with the tumor size, histological type and patient's age of the mammary phyllodes tumors.